Astrazeneca ADR Stock
Your prediction
Astrazeneca ADR Stock
A loss of -1.230% shows a downward development for Astrazeneca ADR.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Astrazeneca ADR stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Astrazeneca ADR in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Astrazeneca ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Astrazeneca ADR | -1.230% | 0.621% | 3.185% | 24.615% | 2.532% | 24.233% | 86.636% |
| GSK plc ADR | -1.420% | -3.704% | 0.971% | 27.607% | -0.478% | 26.061% | 4.654% |
| Bayer AG ADR | 1.900% | 10.309% | 24.419% | 98.148% | 21.591% | -24.648% | -18.939% |
| Teva Pharmaceutical Industries Ltd ADR | -1.460% | -4.610% | 3.462% | 25.701% | 0.000% | 175.615% | 160.155% |
News
1 Quantum Computing Stock to Buy that Could Soar in 2026
Quantum computing is moving from the theoretical to the commercially applicable, but only one company has achieved 99.99% two-qubit gate fidelity (a measure of results accuracy). That company is
3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now
Valuations for many stocks are sky-high, and that can make now an unappealing time to invest in the stock market. However, there are still some great value buys that don't involve taking on a lot of
Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards
MIAMI, FLORIDA / ACCESS Newswire / December 16, 2025 / AstraZeneca, Eastman, Kraft Heinz, and P&G have been recognized for their outstanding contribution at the recent OMP Conference. The
